Literature DB >> 17050607

The S segment of Punta Toro virus (Bunyaviridae, Phlebovirus) is a major determinant of lethality in the Syrian hamster and codes for a type I interferon antagonist.

Lucy A Perrone1, Krishna Narayanan, Melissa Worthy, C J Peters.   

Abstract

Two strains of Punta Toro virus (PTV), isolated from febrile humans in Panama, cause a differential pathogenesis in Syrian hamsters, which could be a useful model for understanding the virulence characteristics and differential outcomes in other phleboviral infections such as Rift Valley fever virus. Genetic reassortants produced between the lethal Adames (A/A/A) and nonlethal Balliet (B/B/B) strains were used in this study to investigate viral genetic determinants for pathogenesis and lethality in the hamster model. The S segment was revealed to be a critical genome segment, determining lethality with log(10) 50% lethal doses for each PTV genotype as follows (L/M/S convention): A/A/A, <0.7; B/A/A, <0.7; A/B/A, 1.5; B/B/A, 2.2; B/A/B, 4.7; A/B/B, >4.7; A/A/B, >4.7; B/B/B, >4.7. In addition, the Adames strain inhibits the induction of alpha/beta interferon (IFN-alpha/beta) in vivo and in vitro and inhibits the activation of the IFN-beta promoter. Expression of the PTV Adames NSs protein, encoded by the S RNA segment, inhibited the virus-mediated induction of an IFN-beta promoter-driven reporter gene, suggesting that PTV NSs functions as a type I IFN antagonist. Taken together, these data indicate a mechanism of pathogenesis in which the suppression of the type I IFN response early during PTV infection leads to early and uncontrolled viral replication and, ultimately, hamster death. This study contributes to our understanding of Phlebovirus pathogenesis and identifies potential targets for immune modulation to increase host survival.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17050607      PMCID: PMC1797479          DOI: 10.1128/JVI.01074-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Induction of severe disease in hamsters by two sandfly fever group viruses, Punta toro and Gabek Forest (Phlebovirus, Bunyaviridae), similar to that caused by Rift Valley fever virus.

Authors:  Ann F Fisher; Robert B Tesh; Jessica Tonry; Hilda Guzman; Dongying Liu; Shu-Yuan Xiao
Journal:  Am J Trop Med Hyg       Date:  2003-09       Impact factor: 2.345

2.  Virulence of La Crosse virus is under polygenic control.

Authors:  R S Janssen; N Nathanson; M J Endres; F Gonzalez-Scarano
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

3.  Epidemic Rift Valley fever in Egypt: observations of the spectrum of human illness.

Authors:  L W Laughlin; J M Meegan; L J Strausbaugh; D M Morens; R H Watten
Journal:  Trans R Soc Trop Med Hyg       Date:  1979       Impact factor: 2.184

4.  Studies on the antigenic relationship among phleboviruses.

Authors:  R B Tesh; C J Peters; J M Meegan
Journal:  Am J Trop Med Hyg       Date:  1982-01       Impact factor: 2.345

5.  Production, partial purification, and characterization of Syrian hamster interferon.

Authors:  E Bollin
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

6.  Role of the middle-sized bunyavirus RNA segment in mouse virulence.

Authors:  R E Shope; E J Rozhon; D H Bishop
Journal:  Virology       Date:  1981-10-15       Impact factor: 3.616

7.  NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription.

Authors:  Agnès Billecocq; Martin Spiegel; Pierre Vialat; Alain Kohl; Friedemann Weber; Michèle Bouloy; Otto Haller
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  Serological studies on the epidemiology of sandfly fever in the Old World.

Authors:  R B Tesh; S Saidi; S J Gajdamovic; F Rodhain; J Vesenjak-Hirjan
Journal:  Bull World Health Organ       Date:  1976       Impact factor: 9.408

9.  Identification of a major non-structural protein in the nuclei of Rift Valley fever virus-infected cells.

Authors:  J K Struthers; R Swanepoel
Journal:  J Gen Virol       Date:  1982-06       Impact factor: 3.891

10.  Clinical and serologic responses of volunteers infected with phlebotomus fever virus (Sicilian type).

Authors:  P J Bartelloni; R B Tesh
Journal:  Am J Trop Med Hyg       Date:  1976-05       Impact factor: 2.345

View more
  28 in total

1.  Attenuation of pathogenic Rift Valley fever virus strain through the chimeric S-segment encoding sandfly fever phlebovirus NSs or a dominant-negative PKR.

Authors:  Shoko Nishiyama; Olga A L Slack; Nandadeva Lokugamage; Terence E Hill; Terry L Juelich; Lihong Zhang; Jennifer K Smith; David Perez; Bin Gong; Alexander N Freiberg; Tetsuro Ikegami
Journal:  Virulence       Date:  2016-06-01       Impact factor: 5.882

2.  The two faces of Rift Valley fever virus virulence factor NSs: The development of a vaccine and the elucidation of pathogenesis.

Authors:  Satoko Yamaoka; Hideki Ebihara
Journal:  Virulence       Date:  2016-07-18       Impact factor: 5.882

3.  Toscana virus NSs protein promotes degradation of double-stranded RNA-dependent protein kinase.

Authors:  Birte Kalveram; Tetsuro Ikegami
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

4.  NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase.

Authors:  Matthias Habjan; Andreas Pichlmair; Richard M Elliott; Anna K Overby; Timo Glatter; Matthias Gstaiger; Giulio Superti-Furga; Hermann Unger; Friedemann Weber
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

5.  Molecular biology of rift valley Fever virus.

Authors:  Michele Bouloy; Friedemann Weber
Journal:  Open Virol J       Date:  2010-04-22

6.  New World hantaviruses activate IFNlambda production in type I IFN-deficient vero E6 cells.

Authors:  Joseph Prescott; Pamela Hall; Mariana Acuna-Retamar; Chunyan Ye; Marc G Wathelet; Hideki Ebihara; Heinz Feldmann; Brian Hjelle
Journal:  PLoS One       Date:  2010-06-17       Impact factor: 3.240

7.  Punta Toro virus (Bunyaviridae, Phlebovirus) infection in mice: strain differences in pathogenesis and host interferon response.

Authors:  Michelle Mendenhall; Min-Hui Wong; Ramona Skirpstunas; John D Morrey; Brian B Gowen
Journal:  Virology       Date:  2009-09-26       Impact factor: 3.616

8.  A five-amino-acid deletion of the eastern equine encephalitis virus capsid protein attenuates replication in mammalian systems but not in mosquito cells.

Authors:  Patricia V Aguilar; Lawrence W Leung; Eryu Wang; Scott C Weaver; Christopher F Basler
Journal:  J Virol       Date:  2008-05-14       Impact factor: 5.103

9.  Characterization of Shuni viruses detected in Israel.

Authors:  Natalia Golender; Kerstin Wernike; Velizar Bumbarov; Andrea Aebischer; Alexander Panshin; Maria Jenckel; Yevgeny Khinich; Martin Beer
Journal:  Virus Genes       Date:  2016-08-19       Impact factor: 2.332

Review 10.  Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines.

Authors:  Michele Bouloy; Ramon Flick
Journal:  Antiviral Res       Date:  2009-08-12       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.